Lion Head Co., Ltd. announced that it plans to purchase 97.4399% of the shares of Hangzhou Lipo Technology Co., Ltd. held by 14 counterparties, including Wang Xulongqi and Deng Haoyu, and issue shares to Chongqing Yiyuan and Yicheng Enterprise Management Company to raise capital through the issuance of shares and cash payment. The Shanghai Stock Exchange suspended the review on May 31, 2026 due to the expiration of the evaluation report. As of the announcement date, the company, together with intermediaries, updated the evaluation data of application documents to December 31, 2025 to revise, supplement and improve documents such as restructuring reports and responses to audit inquiries.

Lion Head Co., Ltd. announced that it plans to purchase 97.4399% of the shares of Hangzhou Lipo Technology Co., Ltd. held by 14 counterparties, including Wang Xulongqi and Deng Haoyu, and issue shares to Chongqing Yiyuan and Yicheng Enterprise Management Company to raise capital through the issuance of shares and cash payment. The Shanghai Stock Exchange suspended the review on May 31, 2026 due to the expiration of the evaluation report. As of the announcement date, the company, together with intermediaries, updated the evaluation data of application documents to December 31, 2025 to revise, supplement and improve documents such as restructuring reports and responses to audit inquiries.